Medical Waste Due to Intravitreal Injection Procedures in a Retina Clinic.
Thomas W CameronLoi V VoLily K EmersonM Vaughn EmersonGeoffrey G EmersonPublished in: Journal of vitreoretinal diseases (2021)
Waste due to shipping of medication is a major opportunity for reducing the environmental impact of intravitreal injections. Buying in bulk is a simple way for retina practices to reduce waste. Manufacturers should consider less bulky packaging for branded intravitreal injections; distributors and outsourcing facilities should consider take-back programs to reuse coolers and cold packs. Improved sustainability in the treatment of retinal disease is achievable but requires awareness and optimization of a clinic's routine.
Keyphrases
- diabetic retinopathy
- life cycle
- primary care
- optical coherence tomography
- vascular endothelial growth factor
- healthcare
- heavy metals
- ultrasound guided
- municipal solid waste
- sewage sludge
- age related macular degeneration
- optic nerve
- platelet rich plasma
- public health
- clinical practice
- adverse drug
- climate change
- electronic health record